COSCIENS Biopharma Inc. SC 13G and SC 13G/A reports

Location
C/O Norton Rose Fulbright Canada Llp, 222 Bay Street, Suite 3000, Po Box 53, Toronto, Ontario, Canada
State of incorporation
Ontario, Canada
Fiscal year end
December 31
Data updated at
9/7/2024, 01:24 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Jun 6, 2024
SC 13G/A Report Feb 11, 2022
SC 13G/A Report AMENDMENT NO. 2 TO SCHEDULE 13G Feb 11, 2022
SC 13G/A Report Feb 16, 2021
SC 13G/A Report AMENDMENT NO. 1 Feb 12, 2021
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Jan 29, 2021
SC 13G Report SCHEDULE 13G Jul 10, 2020
SC 13G Report Jul 7, 2020
SC 13G Report Feb 28, 2020
SC 13G/A Report Feb 14, 2020
SC 13G/A Report AETERNA ZENTARIS INC. Jan 23, 2020
SC 13G Report Sep 27, 2019
SC 13G Report AETERNA ZENTARIS INC. Sep 25, 2019
SC 13G/A Report AMENDMENT NO. 1 Mar 18, 2019
SC 13G Report Feb 11, 2019
SC 13G/A Report SABBY 13G-A AEZS 1.09.17 Jan 9, 2017
SC 13G/A Report SC 13G/A Feb 12, 2016
SC 13G/A Report SABBY 13G-A AEZS 1.14.16 Jan 14, 2016
SC 13G Report SABBY AEZS 13G 12.17.15 Dec 17, 2015
SC 13G Report SC 13G Mar 13, 2015
SC 13G/A Report SC 13G/A Feb 13, 2014
SC 13G Report SC 13G Nov 29, 2013
SC 13G Report Nov 19, 2012
SC 13G/A Report SC 13G/A Feb 14, 2011
SC 13G/A Report FONDS Jun 16, 2010
SC 13G Report SC 13G Apr 26, 2010
SC 13G Report SC 13G Feb 11, 2010